Nanobacterie Overview
- Founded
- 2008
- Status
- Private
- Latest Deal Type
- Accelerator/Inc
- Investors
- 1
Nanobacterie General Information
Description
Developer of a magnetic nanoparticles based treatment therapy designed to treat cancerous tumors. The company's therapy uses nanoparticles containing iron oxide, which are introduced into solid tumors and then subjected to an alternating magnetic field, enabling doctors to dissolve tumor tissue through this therapy.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Primary Office
- Batiment 201
- Université Paris-Sud
- 91405 Orsay
- France
Nanobacterie Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
Nanobacterie Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Laurence Rivain | Founder |
Nanobacterie Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Agoranov | Accelerator/Incubator | 000 0000 | 000000 0 |